Could mutated blood cells hold the key to lower Alzheimer’s risk?

Share this article Acadia will move forward with the Nuplazid patent formulation case scheduled for a December 2024 trial. Credit: Sergey Mironov/Shutterstock.com Acadia Pharmaceuticals gained

The Supreme Court appeared divided during oral arguments Wednesday in a case involving whether states can determine if emergency departments may provide abortions to pregnant

As the hepatitis virus infectious burden remains an issue, Aligos Therapeutics CEO highlights the opportunity for pharmaceutical companies to find success by offering new treatment